Angiogenic cytokines in renovascular disease: Do they have potential for therapeutic use?

Journal of the American Society of Hypertension

Volumn 7, Issue 2, 2013, Pages 180-190

  Chade, Alejandro R ^a   Stewart, Nicholas ^a  

^a UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

Author keywords

angiogenesis; cytokines; Kidney; microcirculation; renovascular disease

Indexed keywords

CYTOKINE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; PLATELET DERIVED GROWTH FACTOR C; SCATTER FACTOR; VASCULOTROPIN; VASCULOTROPIN 121; VASCULOTROPIN 165; VASCULOTROPIN INHIBITOR;

ANTIANGIOGENIC THERAPY; BRAIN INJURY; CANCER CHEMOTHERAPY; CEREBROVASCULAR ACCIDENT; CHRONIC KIDNEY DISEASE; COLON CANCER; CORONARY ARTERY DISEASE; CRITICAL LIMB ISCHEMIA; DISEASE COURSE; GLOMERULONEPHRITIS; HUMAN; HYPERTENSION; KIDNEY DYSFUNCTION; KIDNEY INJURY; KIDNEY ISCHEMIA; MICROANGIOPATHY; MICROCIRCULATION; MUSCLE ISCHEMIA; NONHUMAN; PRIORITY JOURNAL; RENAL PROTECTION; RENOVASCULAR DISEASE; REVIEW; SOLID TUMOR; THROMBOTIC THROMBOCYTOPENIC PURPURA; URETER OBSTRUCTION;

ANIMALS; CYTOKINES; DISEASE PROGRESSION; HUMANS; HYPERTENSION, RENOVASCULAR; MICROCIRCULATION; NEOVASCULARIZATION, PHYSIOLOGIC;

EID: 84875368334     PISSN: 19331711     EISSN: 18787436     Source Type: Journal    
DOI: 10.1016/j.jash.2013.01.004     Document Type: Review

References (100)

1. US Renal Data System USRDS 2010 Annual Data Report; Atlas of End-Stage Renal Disease in the United States 2011 National Institutes of Health, National Institute of Diabetes, and Digestive and Kidney Diseases Bethesda, MD
2. L.D. Dworkin, and T. Murphy Is there any reason to stent atherosclerotic renal artery stenosis? Am J Kidney Dis 56 2010 259 263
3. K.J. Hansen, M.S. Edwards, T.E. Craven, G.S. Cherr, S.A. Jackson, and R.G. Appel Prevalence of renovascular disease in the elderly: a population-based study J Vasc Surg 36 2002 443 451
4. D.G. Hackam, F. Wu, P. Li, P.C. Austin, S.W. Tobe, and M.M. Mamdani Statins and renovascular disease in the elderly: a population-based cohort study Eur Heart J 32 2011 598 610
5. C. Chrysochou, R.N. Foley, J.F. Young, K. Khavandi, C.M. Cheung, and P.A. Kalra Dispelling the myth: the use of renin-angiotensin blockade in atheromatous renovascular disease Nephrol Dial Transplant 27 2012 1403 1409
6. X.Y. Zhu, E. Daghini, A.R. Chade, D. Versari, J.D. Krier, and K.B. Textor Myocardial microvascular function during acute coronary artery stenosis: Effect of hypertension and hypercholesterolaemia Cardiovasc Res 83 2009 371 380
7. C.J. Cooper, and T.P. Murphy Is renal artery stenting the correct treatment of renal artery stenosis? The case for renal artery stenting for treatment of renal artery stenosis Circulation 115 2007 263 269 discussion, 270
8. L.D. Dworkin, and K.A. Jamerson Is renal artery stenting the correct treatment of renal artery stenosis? Case against angioplasty and stenting of atherosclerotic renal artery stenosis Circulation 115 2007 271 276 discussion, 276
9. B.C. van Jaarsveld, P. Krijnen, H. Pieterman, F.H. Derkx, J. Deinum, and C.T. Postma The effect of balloon angioplasty on hypertension in atherosclerotic renal-artery stenosis. Dutch Renal Artery Stenosis Intervention Cooperative Study Group N Engl J Med 342 2000 1007 1014
10. J. Webster, F. Marshall, M. Abdalla, A. Dominiczak, R. Edwards, and C.G. Isles Randomised comparison of percutaneous angioplasty vs continued medical therapy for hypertensive patients with atheromatous renal artery stenosis. Scottish and Newcastle Renal Artery Stenosis Collaborative Group J Hum Hypertens 12 1998 329 335
11. T.P. Sarac Influence and critique of the ASTRAL and CORAL Trials Semin Vasc Surg 24 2011 162 166
12. R.J. Johnson, B. Rodriguez-Iturbe, G.F. Schreiner, and J. Herrera-Acosta Hypertension: A microvascular and tubulointerstitial disease J Hypertens Suppl 20 2002 S1 S7
13. A.J. Krentz, G. Clough, and C.D. Byrne Interactions between microvascular and macrovascular disease in diabetes: Pathophysiology and therapeutic implications Diabetes Obes Metab 9 2007 781 791
14. L. Kuo, M.J. Davis, M.S. Cannon, and W.M. Chilian Pathophysiological consequences of atherosclerosis extend into the coronary microcirculation. Restoration of endothelium-dependent responses by L-arginine Circ Res 70 1992 465 476
15. T. Uzu, Y. Kida, N. Shirahashi, T. Harada, A. Yamauchi, and M. Nomura Cerebral microvascular disease predicts renal failure in type 2 diabetes J Am Soc Nephrol 21 2010 520 526
16. A.R. Chade Renovascular disease, microcirculation, and the progression of renal injury: Role of angiogenesis Am J Physiol Regul Integr Comp Physiol 300 2011 R783 R790
17. N. Koivuviita, K. Liukko, N. Kudomi, V. Oikonen, R. Tertti, and I. Manner The effect of revascularization of renal artery stenosis on renal perfusion in patients with atherosclerotic renovascular disease Nephrol Dial Transplant 27 2012 3843 3848
18. A.R. Chade, and S. Kelsen Reversal of renal dysfunction by targeted administration of VEGF into the stenotic kidney: A novel potential therapeutic approach Am J Physiol Renal Physiol 302 2012 F1432 F1450
19. A.R. Chade, X. Zhu, O.P. Mushin, C. Napoli, A. Lerman, and L.O. Lerman Simvastatin promotes angiogenesis and prevents microvascular remodeling in chronic renal ischemia FASEB J 20 2006 1706 1708
20. R. Iliescu, S.R. Fernandez, S. Kelsen, C. Maric, and A.R. Chade Role of renal microcirculation in experimental renovascular disease Nephrol Dial Transplant 25 2010 1079 1087
21. X.Y. Zhu, A.R. Chade, M. Rodriguez-Porcel, M.D. Bentley, E.L. Ritman, and A. Lerman Cortical microvascular remodeling in the stenotic kidney: Role of increased oxidative stress Arterioscler Thromb Vasc Biol 24 2004 1854 1859
22. A.R. Chade, X. Zhu, R. Lavi, J.D. Krier, S. Pislaru, and R.D. Simari Endothelial progenitor cells restore renal function in chronic experimental renovascular disease Circulation 119 2009 547 557
23. A.R. Chade, X.Y. Zhu, J.P. Grande, J.D. Krier, A. Lerman, and L.O. Lerman Simvastatin abates development of renal fibrosis in experimental renovascular disease J Hypertens 26 2008 1651 1660
24. N. Futrakul, P. Butthep, N. Laohareungpanya, P. Chaisuriya, and K. Ratanabanangkoon A defective angiogenesis in chronic kidney disease Ren Fail 30 2008 215 217
25. M. Duranay, M. Kanbay, H. Akay, S. Unverdi, H. Surer, and M. Altay Nebivolol improves renal function in patients who underwent angioplasty due to renal artery stenosis: A pilot study Nephron Clin Practi 114 2010 c213 c217
26. M. Sila-asna, A. Bunyaratvej, P. Futrakul, and N. Futrakul Renal microvascular abnormality in chronic kidney disease Ren Fail 28 2006 609 610
27. N. Ferrara, K.J. Hillan, H.P. Gerber, and W. Novotny Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer Nat Rev Drug Discov 3 2004 391 400
28. R.K. Jain, D.G. Duda, J.W. Clark, and J.S. Loeffler Lessons from phase III clinical trials on anti-VEGF therapy for cancer Nat Clin Pract Oncol 3 2006 24 40
29. T. Osada, G. Chong, R. Tansik, T. Hong, N. Spector, and R. Kumar The effect of anti-VEGF therapy on immature myeloid cell and dendritic cells in cancer patients Cancer Immunol Immunother 57 2008 1115 1124
30. V. Eremina, J.A. Jefferson, J. Kowalewska, H. Hochster, M. Haas, and J. Weisstuch VEGF inhibition and renal thrombotic microangiopathy N Engl J Med 358 2008 1129 1136
31. T. Kamba, and D.M. McDonald Mechanisms of adverse effects of anti-VEGF therapy for cancer Br J Cancer 96 2007 1788 1795
32. N. Futrakul, P. Butthep, S. Chunhakarn, W. Banyatsappasin, P. Futrakul, and V. Sitprija A deficient VEGF enhances endothelial cell loss and impaired renal function Ren Fail 28 2006 449
33. N. Futrakul, P. Butthep, and P. Futrakul Altered vascular homeostasis in chronic kidney disease Clin Hemorheol Microcirc 38 2008 201 207
34. M.A. Moore, K. Hattori, B. Heissig, J.H. Shieh, S. Dias, and R.G. Crystal Mobilization of endothelial and hematopoietic stem and progenitor cells by adenovector-mediated elevation of serum levels of SDF-1, VEGF, and angiopoietin-1 Ann N Y Acad Sci 938 2001 36 45 discussion, 45-7
35. D. Zisa, A. Shabbir, M. Mastri, G. Suzuki, and T. Lee Intramuscular VEGF repairs the failing heart: Role of host-derived growth factors and mobilization of progenitor cells Am J Physiol Regul Integr Comp Physiol 297 2009 R1503 R1515
36. V. Eremina, and S.E. Quaggin The role of VEGF-A in glomerular development and function Curr Opin Nephrol Hypertens 13 2004 9 15
37. N. Ferrara, H.P. Gerber, and J. LeCouter The biology of VEGF and its receptors Nat Med 9 2003 669 676
38. R.C. Hendel, T.D. Henry, K. Rocha-Singh, J.M. Isner, D.J. Kereiakes, and F.J. Giordano Effect of intracoronary recombinant human vascular endothelial growth factor on myocardial perfusion: Evidence for a dose-dependent effect Circulation 101 2000 118 121
39. T.D. Henry, K. Rocha-Singh, J.M. Isner, D.J. Kereiakes, F.J. Giordano, and M. Simons Intracoronary administration of recombinant human vascular endothelial growth factor to patients with coronary artery disease Am Heart J 142 2001 872 880
40. R. Wafai, E.M. Tudor, J.A. Angus, and C.E. Wright Vascular effects of FGF-2 and VEGF-B in rabbits with bilateral hind limb ischemia J Vasc Res 46 2009 45 54
41. D.H. Kang, J. Hughes, M. Mazzali, G.F. Schreiner, and R.J. Johnson Impaired angiogenesis in the remnant kidney model: II. Vascular endothelial growth factor administration reduces renal fibrosis and stabilizes renal function J Am Soc Nephrol 12 2001 1448 1457
42. D.P. Basile, K. Fredrich, B. Chelladurai, E.C. Leonard, and A.R. Parrish Renal ischemia reperfusion inhibits VEGF expression and induces ADAMTS-1, a novel VEGF inhibitor Am J Physiol Renal Physiol 294 2008 F928 F936
43. E.C. Leonard, J.L. Friedrich, and D.P. Basile VEGF-121 preserves renal microvessel structure and ameliorates secondary renal disease following acute kidney injury Am J Physiol Renal Physiol 295 2008 F1648 F1657
44. A.R. Chade, and S. Kelsen Renal microvascular disease determines the responses to revascularization in experimental renovascular disease Circ Cardiovasc Interv 3 2010 376 383
45. C.M. Findley, M.J. Cudmore, A. Ahmed, and C.D. Kontos VEGF induces Tie2 shedding via a phosphoinositide 3-kinase/Akt dependent pathway to modulate Tie2 signaling Arterioscler Thromb Vasc Biol 27 2007 2619 2626
46. J. Saif, T.M. Schwarz, D.Y. Chau, J. Henstock, P. Sami, and S.F. Leicht Combination of injectable multiple growth factor-releasing scaffolds and cell therapy as an advanced modality to enhance tissue neovascularization Arterioscler Thromb Vasc Biol 30 2010 1897 1904
47. J.X. Chen, and A. Stinnett Disruption of Ang-1/Tie-2 signaling contributes to the impaired myocardial vascular maturation and angiogenesis in type II diabetic mice Arterioscler Thromb Vasc Biol 28 2008 1606 1613
48. P.R. Somanath, J. Chen, and T.V. Byzova Akt1 is necessary for the vascular maturation and angiogenesis during cutaneous wound healing Angiogenesis 11 2008 277 288
49. Y. Lu, Y. Xiong, Y. Huo, J. Han, X. Yang, and R. Zhang Grb-2-associated binder 1 (Gab1) regulates postnatal ischemic and VEGF-induced angiogenesis through the protein kinase A-endothelial NOS pathway Proc Natl Acad Sci U S A 108 2011 2957 2962
50. T. Morita, Y. Kakinuma, A. Kurabayashi, M. Fujieda, T. Sato, and T. Shuin Conditional VHL gene deletion activates a local NO-VEGF axis in a balanced manner reinforcing resistance to endothelium-targeted glomerulonephropathy Nephrol Dial Transplant 26 2011 4023 4031
51. Y. Liu Hepatocyte growth factor and the kidney Curr Opin Nephrol Hypertens 11 2002 23 30
52. Y. Liu Hepatocyte growth factor in kidney fibrosis: Therapeutic potential and mechanisms of action Am J Physiol Renal Physiol 287 2004 F7 F16
53. R. Gong, A. Rifai, and L.D. Dworkin Anti-inflammatory effect of hepatocyte growth factor in chronic kidney disease: Targeting the inflamed vascular endothelium J Am Soc Nephrol 17 2006 2464 2473
54. R. Gong, A. Rifai, E.M. Tolbert, P. Biswas, J.N. Centracchio, and L.D. Dworkin Hepatocyte growth factor ameliorates renal interstitial inflammation in rat remnant kidney by modulating tubular expression of macrophage chemoattractant protein-1 and RANTES J Am Soc Nephrol 15 2004 2868 2881
55. K. Ono, A. Matsumori, T. Shioi, Y. Furukawa, and S. Sasayama Enhanced expression of hepatocyte growth factor/c-Met by myocardial ischemia and reperfusion in a rat model Circulation 95 1997 2552 2558
56. M.Z. Zhao, N. Nonoguchi, N. Ikeda, T. Watanabe, D. Furutama, and D. Miyazawa Novel therapeutic strategy for stroke in rats by bone marrow stromal cells and ex vivo HGF gene transfer with HSV-1 vector J Cereb Blood Flow Metab 26 2006 1176 1188
57. Y. Yoshitomi, S. Kojima, T. Umemoto, K. Kubo, Y. Matsumoto, and M. Yano Serum hepatocyte growth factor in patients with peripheral arterial occlusive disease J Clin Endocrinol Metab 84 1999 2425 2428
58. G.M. Ellison, D. Torella, S. Dellegrottaglie, C. Perez-Martinez, A. Perez de Prado, and C. Vicinanza Endogenous cardiac stem cell activation by insulin-like growth factor-1/hepatocyte growth factor intracoronary injection fosters survival and regeneration of the infarcted pig heart J Am Coll Cardiol 58 2011 977 986
59. S. Kelsen, J.E. Hall, and A.R. Chade Endothelin-A receptor blockade slows the progression of renal injury in experimental renovascular disease Am J Physiol Renal Physiol 301 2011 F218 F225
60. Stewart N, Chade AR. Renoprotective effects of hepatocyte growth factor in the stenotic kidney. Am J Physiol Renal Physiol [Epub ahead of print December 26, 2012].
61. A. Anghel, G. Taranu, E. Seclaman, A. Rata, L. Tamas, and H. Moldovan Safety of vascular endothelial and hepatocyte growth factor gene therapy in patients with critical limb ischemia Curr Neurovasc Res 8 2011 183 189
62. R.J. Powell, M. Simons, F.O. Mendelsohn, G. Daniel, T.D. Henry, and M. Koga Results of a double-blind, placebo-controlled study to assess the safety of intramuscular injection of hepatocyte growth factor plasmid to improve limb perfusion in patients with critical limb ischemia Circulation 118 2008 58 65
63. R. Morishita, H. Makino, M. Aoki, N. Hashiya, K. Yamasaki, and J. Azuma Phase I/IIa clinical trial of therapeutic angiogenesis using hepatocyte growth factor gene transfer to treat critical limb ischemia Arterioscler Thromb Vasc Biol 31 2011 713 720
64. J. Belch, W.R. Hiatt, I. Baumgartner, I.V. Driver, S. Nikol, and L. Norgren Effect of fibroblast growth factor NV1FGF on amputation and death: A randomised placebo-controlled trial of gene therapy in critical limb ischaemia Lancet 377 2011 1929 1937
65. S. Nikol, I. Baumgartner, E. Van Belle, C. Diehm, A. Visona, and M.C. Capogrossi Therapeutic angiogenesis with intramuscular NV1FGF improves amputation-free survival in patients with critical limb ischemia Mol Ther 16 2008 972 978
66. N. van Royen, S.H. Schirmer, B. Atasever, C.Y. Behrens, D. Ubbink, and E.E. Buschmann START Trial: A pilot study on STimulation of ARTeriogenesis using subcutaneous application of granulocyte-macrophage colony-stimulating factor as a new treatment for peripheral vascular disease Circulation 112 2005 1040 1046
67. D. Carev, M. Saraga, and M. Saraga-Babic Involvement of FGF and BMP family proteins and VEGF in early human kidney development Histol Histopathol 23 2008 853 862
68. N. Emoto, O. Isozaki, E. Ohmura, F. Ito, T. Tsushima, and K. Shizume Basic fibroblast growth factor (FGF-2) in renal cell carcinoma, which is indistinguishable from that in normal kidney, is involved in renal cell carcinoma growth J Urol 152 1994 1626 1631
69. T. Ichimura, J.A. Maier, T. Maciag, G. Zhang, and J.L. Stevens FGF-1 in normal and regenerating kidney: expression in mononuclear, interstitial, and regenerating epithelial cells Am J Physiol 269 1995 F653 F662
70. A. Kirov, M. Duarte, J. Guay, M. Karolak, C. Yan, and L. Oxburgh Transgenic expression of nonclassically secreted FGF suppresses kidney repair PLoS One 7 2012 e36485
71. S. Villanueva, C. Cespedes, A. Gonzalez, and C.P. Vio bFGF induces an earlier expression of nephrogenic proteins after ischemic acute renal failure Am J Physiol Regul Integr Comp Physiol 291 2006 R1677 R1687
72. S. Villanueva, C. Cespedes, A.A. Gonzalez, E. Roessler, and C.P. Vio Inhibition of bFGF-receptor type 2 increases kidney damage and suppresses nephrogenic protein expression after ischemic acute renal failure Am J Physiol Regul Integr Comp Physiol 294 2008 R819 R828
73. K. Sarkar, K. Fox-Talbot, C. Steenbergen, M. Bosch-Marce, and G.L. Semenza Adenoviral transfer of HIF-1alpha enhances vascular responses to critical limb ischemia in diabetic mice Proc Natl Acad Sci U S A 106 2009 18769 18774
74. K.A. Vincent, K.G. Shyu, Y. Luo, M. Magner, R.A. Tio, and C. Jiang Angiogenesis is induced in a rabbit model of hindlimb ischemia by naked DNA encoding an HIF-1alpha/VP16 hybrid transcription factor Circulation 102 2000 2255 2261
75. M.A. Creager Beta-blockers for vascular surgery and angioplasty for renal artery stenosis Rev Cardiovasc Med 2 2001 25 26
76. P. Lindahl, M. Hellstrom, M. Kalen, L. Karlsson, M. Pekny, and M. Pekna Paracrine PDGF-B/PDGF-Rbeta signaling controls mesangial cell development in kidney glomeruli Development 125 1998 3313 3322
77. D.P. Hyink, and D.R. Abrahamson Origin of the glomerular vasculature in the developing kidney Semin Nephrol 15 1995 300 314
78. J. Andrae, R. Gallini, and C. Betsholtz Role of platelet-derived growth factors in physiology and medicine Genes Dev 22 2008 1276 1312
79. J. Floege, F. Eitner, and C.E. Alpers A new look at platelet-derived growth factor in renal disease J Am Soc Nephrol 19 2008 12 23
80. B. Fellstrom, L. Klareskog, C.H. Heldin, E. Larsson, L. Ronnstrand, and L. Terracio Platelet-derived growth factor receptors in the kidney-upregulated expression in inflammation Kidney Int 36 1989 1099 1102
81. Y.T. Chen, F.C. Chang, C.F. Wu, Y.H. Chou, H.L. Hsu, and W.C. Chiang Platelet-derived growth factor receptor signaling activates pericyte- myofibroblast transition in obstructive and post-ischemic kidney fibrosis Kidney Int 80 2011 1170 1181
82. J. Floege, M.W. Burns, C.E. Alpers, A. Yoshimura, P. Pritzl, and K. Gordon Glomerular cell proliferation and PDGF expression precede glomerulosclerosis in the remnant kidney model Kidney Int 41 1992 297 309
83. Y. Isaka, Y. Fujiwara, N. Ueda, Y. Kaneda, T. Kamada, and E. Imai Glomerulosclerosis induced by in vivo transfection of transforming growth factor-beta or platelet-derived growth factor gene into the rat kidney J Clin Invest 92 1993 2597 2601
84. T. Ostendorf, U. Kunter, C. van Roeyen, S. Dooley, N. Janjic, and J. Ruckman The effects of platelet-derived growth factor antagonism in experimental glomerulonephritis are independent of the transforming growth factor-beta system J Am Soc Nephrol 13 2002 658 667
85. E.J. van Zoelen, T.M. van Oostwaard, and S.W. de Laat Transforming growth factor-beta and retinoic acid modulate phenotypic transformation of normal rat kidney cells induced by epidermal growth factor and platelet-derived growth factor J Biol Chem 261 1986 5003 5009
86. J. Savikko, J. Rintala, and E. von Willebrand Early short-term platelet-derived growth factor inhibition prevents the development of chronic allograft nephropathy in experimental rat kidney transplantation Transplant Proc 38 2006 3231 3232
87. P. Boor, C.R. van Roeyen, U. Kunter, L. Villa, E. Bucher, and B. Hohenstein PDGF-C mediates glomerular capillary repair Am J Pathol 177 2010 58 69
88. J. Gille, M. Khalik, V. Konig, and R. Kaufmann Hepatocyte growth factor/scatter factor (HGF/SF) induces vascular permeability factor (VPF/VEGF) expression by cultured keratinocytes J Invest Dermatol 111 1998 1160 1165
89. Y. Yamazaki, Y. Nakano, T. Imamura, and T. Morita Augmentation of vascular permeability of VEGF is enhanced by KDR-binding proteins Biochem Biophys Res Commun 355 2007 693 699
90. Y.G. Kim, S.I. Suga, D.H. Kang, J.A. Jefferson, M. Mazzali, and K.L. Gordon Vascular endothelial growth factor accelerates renal recovery in experimental thrombotic microangiopathy Kidney Int 58 2000 2390 2399
91. D.W. Losordo, P.R. Vale, J.F. Symes, C.H. Dunnington, D.D. Esakof, and M. Maysky Gene therapy for myocardial angiogenesis: Initial clinical results with direct myocardial injection of phVEGF165 as sole therapy for myocardial ischemia Circulation 98 1998 2800 2804
92. P. Makarevich, Z. Tsokolaeva, A. Shevelev, I. Rybalkin, E. Shevchenko, and I. Beloglazova Combined transfer of human VEGF165 and HGF genes renders potent angiogenic effect in ischemic skeletal muscle PLoS One 7 2012 e38776
93. T.R. Doeppner, B. Kaltwasser, A. ElAli, A. Zechariah, D.M. Hermann, and M. Bahr Acute hepatocyte growth factor treatment induces long-term neuroprotection and stroke recovery via mechanisms involving neural precursor cell proliferation and differentiation J Cereb Blood Flow Metab 31 2011 1251 1262
94. C. Dai, M.A. Saleem, L.B. Holzman, P. Mathieson, and Y. Liu Hepatocyte growth factor signaling ameliorates podocyte injury and proteinuria Kidney Int 77 2010 962 973
95. A. Efthimiadou, N.K. Nikolettos, M. Lambropoulou, N. Papadopoulos, and E. Kontoleon Angiogenic effect of intramuscular administration of basic fibroblast growth factor in atrophied muscles: An experimental study in the rat Br J Sports Med 40 2006 355 358 discussion, 358
96. A. Efthimiadou, M. Lambropoulou, O. Pagonopoulou, I. Vakalopoulos, N. Papadopoulos, and N. Nikolettos The role of basic-fibroblast growth factor (b-FGF) in cyclosporine-induced nephrotoxicity In Vivo 20 2006 265 269
97. K. Harada, W. Grossman, M. Friedman, E.R. Edelman, P.V. Prasad, and C.S. Keighley Basic fibroblast growth factor improves myocardial function in chronically ischemic porcine hearts J Clin Invest 94 1994 623 630
98. K.A. Mace, D.H. Yu, K.Z. Paydar, N. Boudreau, and D.M. Young Sustained expression of Hif-1alpha in the diabetic environment promotes angiogenesis and cutaneous wound repair Wound Repair Regen 15 2007 636 645
99. T.H. Patel, H. Kimura, C.R. Weiss, G.L. Semenza, and L.V. Hofmann Constitutively active HIF-1alpha improves perfusion and arterial remodeling in an endovascular model of limb ischemia Cardiovasc Res 68 2005 144 154
100. F. Eitner, E. Bucher, C. van Roeyen, U. Kunter, S. Rong, and C. Seikrit PDGF-C is a proinflammatory cytokine that mediates renal interstitial fibrosis J Am Soc Nephrol 19 2008 281 289